医学
腹内脂肪
减肥
脂肪组织
内科学
磁共振成像
胃肠病学
肾脂肪囊
接收机工作特性
优势比
心脏病学
逻辑回归
曲线下面积
前瞻性队列研究
外科
生物标志物
核医学
内分泌学
代谢综合征
放射科
腹部脂肪
内脏脂肪
泌尿科
作者
Ling Luo,Long Teng,Congxiang Shao,Yan Yang,Shuyu Zhuo,Wei Wang,曹筱佩,Zhi Dong,Bihui Zhong,Junzhao Ye
摘要
AIMS: Various visceral adipose tissue depots exhibit heterogeneous metabolic properties. This study aims to explore whether specific abdominal fat compartments differentially predict loss of sustained treatment response to lifestyle interventions in metabolic dysfunction-associated steatotic liver disease (MASLD). MATERIALS AND METHODS: Consecutive treatment-naïve MASLD patients were prospectively enrolled from January 2015 to March 2024, with a 96-week follow-up period. Liver fat content, preperitoneal fat thickness (PFT), peripancreatic mesenteric fat thickness (MFT1), periumbilical mesenteric fat thickness (MFT2) and perirenal fat thickness (PrFT) were quantified using magnetic resonance imaging. Liver stiffness measurement (LSM) was assessed by 2D-SWE. Treatment responses were evaluated at 48 and 96 weeks, and the primary outcome was loss of response at 96 weeks. RESULTS: A total of 631 MASLD patients (mean age: 41.5 ± 13.8 years; 72.0% male) were included. Logistic regression analyses revealed that a greater 48-week relative decrease in MFT1 (per 10% relative reduction), rather than in MFT2, PFT or PrFT, was independently associated with lower odds of losing MRI-PDFF response (OR: 0.48, 95% CI: 0.34-0.69, p < 0.001) and LSM response (OR: 0.53, 95% CI: 0.28-0.99, p = 0.046) at 96 weeks. Receiver operating characteristic curve analyses indicated that relative changes in MFT1 showed discriminatory ability for the loss of MRI-PDFF and LSM responses, with areas under the curves of 0.70 (95% CI: 0.64-0.76) and 0.77 (95% CI: 0.67-0.88), respectively. CONCLUSIONS: Early changes in MFT1 were associated with subsequent loss of response in hepatic steatosis and fibrosis, suggesting potential prognostic value for hepatic response durability in MASLD.
科研通智能强力驱动
Strongly Powered by AbleSci AI